A single dose of psilocybin combined with psychotherapy produced significant improvements in emotional and existential distress in patients with cancer that lasted more than 4 years, according to a published study.
An open study of patients treated with deep brain stimulation for refractory obsessive-compulsive disorder confirms the treatment’s effectiveness and safety in a clinical setting, researchers concluded in a study published online.
A genome-wide association study has identified several human genome regions related to anxiety risk, and provides the first significant genome-wide findings regarding anxiety in people of African ancestry.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
Ben Cort, CEO of Foundry Treatment Center Steamboat Springs in Colorado, discusses the importance of avoiding microaggressions when working with cannabis-dependent patients, as well as the differences between the marijuana of 20 years and the…
By Lisa Rapaport
For young people with asthma, mood disorders are linked with higher odds of visiting the emergency room, a new study suggests.
Compared to young people with asthma but without depression or anxiety, those with anxiety were 22%…